Feasibility and Efficacy of His Bundle Pacing or Left Bundle Pacing Combined With Atrioventricular Node Ablation in Patients With Persistent Atrial Fibrillation and Implantable Cardioverter-Defibrillator Therapy.
Songjie Wang,Shengjie Wu,Lei Xu,Fangyi Xiao,Pugazhendhi Vijayaraman,Lan Su,Weijian Huang,Zachary I Whinnett
DOI: https://doi.org/10.1161/JAHA.119.014253
IF: 6.106
2019-12-15
Journal of the American Heart Association
Abstract:Background Persistent atrial fibrillation may lead to a higher probability of inappropriate shocks in heart failure patients with an implantable cardioverter‐defibrillator (ICD). The aim of this study was to evaluate the impact of His‐Purkinje conduction system pacing combined with atrioventricular node ablation in improving heart function and preventing inappropriate shock therapy in these patients. Methods and Results A total of 86 consecutive patients with persistent atrial fibrillation and heart failure who had indications for ICD implantation were enrolled from January 2010 to March 2018. His‐Purkinje conduction system pacing with ICD and atrioventricular node ablation was attempted in 55 patients, and the remaining patients underwent ICD implantation only. Left ventricular (LV) ejection fraction, LV end‐systolic volume, New York Heart Association (NYHA) classification, shock therapies, and drug therapy were assessed during follow‐up. Overall, 31 patients received ICD implantation with optimal drug therapy (group 1). atrioventricular node ablation combined with His‐Purkinje conduction system pacing was successfully achieved in 52 patients (group 2). During follow‐up, patients in group 2 had lower incidence of inappropriate shock (15.6% versus 0%, P <0.01) and adverse events ( P =0.011). Meanwhile, improvement in LV ejection fraction and reduction in LV end‐systolic volume were significantly higher in group 2 than in group 1 (15% versus 3%, P <0.001; and 40 versus 2 mL, P <0.01, respectively). NYHA functional class improved in both groups from a baseline 2.57±0.68 to 1.73±0.74 in group 1 and 2.73±0.59 to 1.42±0.53 in group 2 ( P <0.01). Conclusions His‐Purkinje conduction system pacing combined with atrioventricular node ablation is feasible and safe with a high success rate in persistent atrial fibrillation patients with heart failure and ICD indication. It can significantly reduce the incidence of inappropriate shocks and improve LV function. Clinical Perspective What Is New? This study is the first to evaluate the impact of His‐Purkinje conduction system pacing (HPSP) combined with atrioventricular node (AVN) ablation in persistent atrial fibrillation patients with heart failure and implantable cardioverter‐defibrillator implantation. HPSP combined with AVN ablation can significantly improve left ventricular function and reduce adverse events (heart failure hospitalization, inappropriate shocks, or death) compared with implantable cardioverter‐defibrillator implantation and drug therapy in patients with persistent atrial fibrillation and heart failure. HPSP combined with AVN ablation was feasible and safe, with a 94.5% success rate in this study. What Are the Clinical Implications? HPSP combined with AVN ablation can be considered in patients with persistent atrial fibrillation and heart failure who do not respond to optimal drug therapy. HPSP combined with AVN ablation may be an important therapeutic option for persistent atrial fibrillation and heart failure patients with recurrent inappropriate shocks caused by AF despite optimal drug therapy. Introduction Implantable cardioverter‐defibrillator (ICD) effectively treats malignant arrhythmias, including persistent ventricular tachycardia (VT), torsades de pointes, and ventricular fibrillation. 1 Randomized controlled trials have shown the effectiveness of ICD in primary and secondary prevention of sudden cardiac death. 2 , 3 , 4 However, inappropriate shock (IS) caused by atrial fibrillation (AF), supraventricular tachycardia, noise, or T‐wave oversensing in ICD recipients has a significant impact on their physical and mental well‐being. 3 , 5 , 6 AF is a common arrhythmia in patients with ICD and heart failure (HF). An epidemiological survey in 2010 showed that the number of patients with AF in the world is estimated to be 33.5 million and is increasing at the rate of -Abstract Truncated-
cardiac & cardiovascular systems